SVANOVIR® BLV gp51-Ab is based on the gp51 envelope protein, enabling the detection of antibodies to BLV during early phase of infection. It fulfils the EU standard E05 (EEC directive 88/406/EEC) for serum/plasma and milk, and has been used successfully in BLV eradication and control programmes worldwide.


The early indicator for bovine leukaemia virus infection (BLV) in cattle

Product Information

Species Bovine
Samples Serum, plasma, individual and pools of ≤ 10
Milk, individual and pools of ≤50
Type Indirect ELISA based on the envelope glycoprotein gp-51
Article number Samples* Plates Format
SV-104884 88 2 Strips
SV-104885 440 10 Plates
SV-104886 920 10 Strips

*Samples: Max. number of samples for analysis, wells for kit controls excluded